CC, KWM, Freshies on CR Pharma’s $1.8 bln HK IPO
BY Chris Thomson |
Clifford Chance and Ji Yuan Law Offices have advised China Resources Pharmaceutical Group, China's second-largest pharmaceuticals manufacturer and distributor, on its $1.8 billion initial public offering on the Hong Kong Stock Exchange.